FDA Says Chantix May Raise Risk for Stroke and Heart Attack

The pharmaceutical litigation attorneys in Florida at Farah & Farah have previously warned about the potential dangerous side effects of Chantix – the smoking cessation drug manufactured by drug giant Pfizer Inc. – which has been linked in some studies to depression, aggression, and suicide. Pfizer recently settled a lawsuit filed by a widow whose husband took his own life after taking the drug.

Now, the U.S. Food and Drug Administration (FDA) is saying that smokers who take Chantix may be at a higher risk for stroke and heart attacks.

Last year, the FDA was concerned about heart risks linked to Chantix, so it ordered Pfizer to conduct additional safety studies on the drug. Pfizer’s study found that smokers who took Chantix for three months suffered more major cardiac events than a group that was given a placebo.

Since the risk of heart attack was fairly rare, it was suggested that the differences between the two groups might be simply be due to chance and not a result of taking Chantix. A recent report from the FDA disagrees with that assessment.

“The data were analyzed many different ways and consistently showed a higher occurrence of events in patients using Chantix, which makes it seem more likely that it is related to the drug and not purely a chance finding,” the FDA report states.

The physician who led the 2011 safety review of Chantix, told Web MD that patients need to be aware of the drug’s risks and that while he doesn’t totally discount the use of Chantix, he tries other safer, cheaper options first to help smokers quit.

If you believe you’ve been harmed by the dangerous side effects of Chantix or any other drug or medication, it is important that you consult with the law firm of Farah & Farah. You may be entitled to compensation for damages. If you have a question about your case, call us at (800) 533-3555.

Badges